OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$65 Million
Joint Bookrunner
Follow-On
February 2025
$204 Million
Joint Lead Bookrunner
Initial Public Offering
January 2025
Featured Insights
Podcasts
August 2025
Director of Access and Policy Research at Johnson & Johnson, Ulrich Neumann, MBA, MSc, MA
Featured Research
August 2025
ABVX / Ph3 ABTECT Induction Data Preview; A Key Value-Inflecting Catalyst for ABVX / Outperform
Articles
June 2025
